Platelets, eicosanoids, and coronary vasospasm.
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D002417:Cattle; D003329:Coronary Vasospasm / Q000097:blood / Q000503:physiopathology*; D003331:Coronary Vessels / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology; D004537:Eicosanoic Acids / Q000097:blood*; D006801:Humans; D066298:In Vitro Techniques; D008784:Methysergide / Q000494:pharmacology; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology; D012459:Salicylates / Q000494:pharmacology; D020156:Salicylic Acid; D014661:Vasoconstriction / Q000187:drug effects*
D001095:Arachidonic Acids; D004537:Eicosanoic Acids; D011450:Prostaglandin Endoperoxides, Synthetic; D012459:Salicylates; D016718:Arachidonic Acid; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D020156:Salicylic Acid; D001241:Aspirin; D008784:Methysergide